TβRI independently activates Smad- and CD2AP-dependent pathways in podocytes

Journal of the American Society of Nephrology

Volumn 20, Issue 10, 2009, Pages 2127-2137

  Xavier, Sandhya ^a   Niranjan, Thiruvur ^a   Krick, Stefanie ^a   Zhang, Taoran ^a   Ju, Wenjun ^a   Shaw, Andrey S ^b   Schiffer, Mario ^c   Böttinger, Erwin P ^a  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^b WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c HANNOVER MEDICAL SCHOOL   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CD2 ASSOCIATED PROTEIN; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN P85; SMAD PROTEIN; SMAD2 PROTEIN; SMAD3 PROTEIN; TRANSFORMING GROWTH FACTOR BETA RECEPTOR; TRANSFORMING GROWTH FACTOR BETA RECEPTOR 1; CD2-ASSOCIATED PROTEIN; CDKN1A PROTEIN, MOUSE; CYCLIN DEPENDENT KINASE INHIBITOR 1A; CYTOSKELETON PROTEIN; PROTEIN KINASE B; PROTEIN SERINE THREONINE KINASE; SIGNAL TRANSDUCING ADAPTOR PROTEIN; SMAD2 PROTEIN, MOUSE; SMAD3 PROTEIN, MOUSE; TGF BETA TYPE I RECEPTOR; TGF-BETA TYPE I RECEPTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CARBOXY TERMINAL SEQUENCE; CELL DIFFERENTIATION; CELL GROWTH; CONTROLLED STUDY; GLOMERULOSCLEROSIS; GROWTH INHIBITION; MOLECULAR INTERACTION; MOUSE; NONHUMAN; PODOCYTE; PRIORITY JOURNAL; PROTEINURIA; TRANSGENIC MOUSE; ANIMAL; C57BL MOUSE; CELL CULTURE; KIDNEY; METABOLISM; PATHOLOGY; PHYSIOLOGY; SCLEROSIS; SIGNAL TRANSDUCTION;

1-PHOSPHATIDYLINOSITOL 3-KINASE; ADAPTOR PROTEINS, SIGNAL TRANSDUCING; ANIMALS; APOPTOSIS; CELLS, CULTURED; CYCLIN-DEPENDENT KINASE INHIBITOR P21; CYTOSKELETAL PROTEINS; KIDNEY; MICE; MICE, INBRED C57BL; PODOCYTES; PROTEIN-SERINE-THREONINE KINASES; PROTEINURIA; PROTO-ONCOGENE PROTEINS C-AKT; RECEPTORS, TRANSFORMING GROWTH FACTOR BETA; SCLEROSIS; SIGNAL TRANSDUCTION; SMAD2 PROTEIN; SMAD3 PROTEIN;

EID: 70349914263     PISSN: 10466673     EISSN: 15333450     Source Type: Journal    
DOI: 10.1681/ASN.2008070806     Document Type: Article

References (41)

1. Moses HL, Serra R: Regulation of differentiation by TGF-beta. Curr Opin Genet Dev 6: 581-586, 1996
2. Roberts AB, Sporn MB: The transforming growth factors-β. In: Handbook of Experimental Pharmacology: Peptide Growth Factors and Their Receptors, 95th Ed., edited by Sporn MB, Roberts AB, Berlin, Springer-Verlag, 1990, pp 419-472
3. Schiffer M, Bitzer M, Roberts IS, Kopp JB, ten Dijke P, Mundel P, Bottinger EP: Apoptosis in podocytes induced by TGF-beta and Smad7. J Clin Invest 108: 807-816, 2001
4. Wu DT, Bitzer M, Ju W, Mundel P, Bottinger EP: TGF-beta concentration specifies differential signaling profiles of growth arrest/differentiation and apoptosis in podocytes. J Am Soc Nephrol 16: 3211-3221, 2005 (Pubitemid 46179327)
5. Wada J, Zhang H, Tsuchiyama Y, Hiragushi K, Hida K, Shikata K, Kanwar YS, Makino H: Gene expression profile in streptozotocin-induced diabetic mice kidneys undergoing glomerulosclerosis. Kidney Int 59: 1363-1373, 2001 (Pubitemid 32281224)
6. Wiggins RC: The spectrum of podocytopathies: A unifying view of glomerular diseases. Kidney Int 71: 1205-1214, 2007
7. Shankland SJ: The podocyte's response to injury: Role in proteinuria and glomerulosclerosis. Kidney Int 69: 2131-2147, 2006 (Pubitemid 43882099)
8. Bottinger EP: TGF-beta in renal injury and disease. Semin Nephrol 27: 309-320, 2007
9. Derynck R, Zhang YE: Smad-dependent and Smad-independent pathways in TGF-beta family signalling. Nature 425: 577-584, 2003 (Pubitemid 37280136)
10. Shi Y, Massague J: Mechanisms of TGF-beta signaling from cell membrane to the nucleus. Cell 113: 685-700, 2003 (Pubitemid 36724933)
11. ten Dijke P, Hill CS: New insights into TGF-beta-Smad signalling. Trends Biochem Sci 29: 265-273, 2004
12. Wrana JL, Attisano L: The Smad pathway. Cytokine Growth Factor Rev 11: 5-13, 2000
13. Moustakas A, Heldin CH: Non-Smad TGF-beta signals. J Cell Sci 118: 3573-3584, 2005
14. Ju W, Ogawa A, Heyer J, Nierhof D, Yu L, Kucherlapati R, Shafritz DA, Bottinger EP: Deletion of Smad2 in mouse liver reveals novel functions in hepatocyte growth and differentiation. Mol Cell Biol 26: 654-667, 2006 (Pubitemid 43089776)
15. Itoh S, Thorikay M, Kowanetz M, Moustakas A, Itoh F, Heldin CH, ten Dijke P: Elucidation of Smad requirement in transforming growth factor-beta type I receptor-induced responses. J Biol Chem 278: 3751-3761, 2003 (Pubitemid 36801101)
16. Mulder KM: Role of Ras and MAPKs in TGFbeta signaling. Cytokine Growth Factor Rev 11: 23-35, 2000
17. Lee MK, Pardoux C, Hall MC, Lee PS, Warburton D, Qing J, Smith SM, Derynck R: TGF-beta activates ERK MAP kinase signalling through direct phosphorylation of ShcA. EMBO J 26: 3957-3967, 2007 (Pubitemid 47367487)
18. Wilkes MC, Mitchell H, Penheiter SG, Dore JJ, Suzuki K, Edens M, Sharma DK, Pagano RE, Leof EB: Transforming growth factor-beta activation of phosphatidylinositol 3-kinase is independent of Smad2 and Smad3 and regulates fibroblast responses via p21-activated kinase-2. Cancer Res 65: 10431-10440, 2005 (Pubitemid 41743737)
19. Bakin AV, Tomlinson AK, Bhowmick NA, Moses HL, Arteaga CL: Phosphatidylinositol-3 kinase function is required for TGFbeta-mediated epithelial to mesenchymal transition and cell migration. J Biol Chem 275: 36803-36810, 2000
20. Schiffer M, Mundel P, Shaw AS, Bottinger EP: A novel role for the adaptor molecule CD2-associated protein in TGF-beta-induced apoptosis. J Biol Chem 279: 37004-37012, 2004
21. Yang YC, Piek E, Zavadil J, Liang D, Xie D, Heyer J, Pavlidis P, Kucherlapati R, Roberts AB, Bottinger EP: Hierarchical model of gene regulation by transforming growth factor beta. Proc Natl Acad Sci U S A 100: 10269-10274, 2003 (Pubitemid 37071868)
22. Massague J, Chen YG: Controlling TGF-beta signaling. Genes Dev 14: 627-644, 2000
23. Mundel P, Reiser J, Zuniga Mejia BA, Pavenstadt H, Davidson GR, Kriz W, Zeller R: Rearrangements of the cytoskeleton and cell contacts induce process formation during differentiation of conditionally immortalized mouse podocyte cell lines. Exp Cell Res 236: 248-258, 1997 (Pubitemid 27452369)
24. Gineitis D, Treisman R: Differential usage of signal transduction pathways defines two types of serum response factor target gene. J Biol Chem 276: 24531-24539, 2001 (Pubitemid 37412916)
25. Zawel L, Dai JL, Buckhaults P, Zhou S, Kinzler KW, Vogelstein B, Kern SE: Human Smad3 and Smad4 are sequence-specific transcription activators. Mol Cell 1: 611-617, 1998 (Pubitemid 128374697)
26. Poser S, Impey S, Trinh K, Xia Z, Storm DR: SRF-dependent gene expression is required for PI3-kinase-regulated cell proliferation. EMBO J 19: 4955-4966, 2000 (Pubitemid 30727352)
27. Huber TB, Hartleben B, Kim J, Schmidts M, Schermer B, Keil A, Egger L, Lecha RL, Borner C, Pavenstadt H, Shaw AS, Walz G, Benzing T: Nephrin and CD2AP associate with phosphoinositide 3-OH kinase and stimulate AKT-dependent signaling. Mol Cell Biol 23: 4917-4928, 2003 (Pubitemid 36793337)
28. van der Poel HG: Mammalian target of rapamycin and 3-phosphatidylinositol 3-kinase pathway inhibition enhances growth inhibition of transforming growth factor-beta1 in prostate cancer cells. J Urol 172: 1333-1337, 2004
29. Sanderson N, Factor V, Nagy P, Kopp J, Kondaiah P, Wakefield L, Roberts AB, Sporn MB, Thorgeirsson SS: Hepatic expression of mature transforming growth factor beta 1 in transgenic mice results in multiple tissue lesions. Proc Natl Acad Sci U S A 92: 2572-2576, 1995
30. Ju W, Eichinger F, Bitzer M, Oh, J, McWeeney S, Berthier CC, Shedden K, Cohen CD, Henger A, Krick S, Kopp JB, Stoeckert CJ Jr, Dikman S, Schroppel B, Thomas DB, Schlondorff D, Kretzler M, Bottinger EP: Renal gene and protein expression signatures for prediction of kidney disease progression. Am J Pathol 174: 2073-2085, 2009
31. Xia W, Mruk DD, Lee WM, Cheng CY: Differential interactions between transforming growth factor-beta3/TbetaR1, TAB1, and CD2AP disrupt blood-testis barrier and Sertoli-germ cell adhesion. J Biol Chem 281: 16799-16813, 2006 (Pubitemid 43909636)
32. Arteaga CL, Tandon AK, Von Hoff DD, Osborne CK: Transforming growth factor beta: Potential autocrine growth inhibitor of estrogen receptor-negative human breast cancer cells. Cancer Res 48: 3898-3904, 1988
33. Yi JY, Shin I, Arteaga CL: Type I transforming growth factor beta receptor binds to and activates phosphatidylinositol 3-kinase. J Biol Chem 280: 10870-10876, 2005 (Pubitemid 40395952)
34. Mao J, Zhang Y, Du L, Dai Y, Yang C, Liang L: Expression profile of nephrin, podocin, and CD2AP in Chinese children with MCNS and IgA nephropathy. Pediatr Nephrol 21: 1666-1675, 2006 (Pubitemid 44390831)
35. Kim JM, Wu H, Green G, Winkler CA, Kopp JB, Miner JH, Unanue ER, Shaw AS: CD2-associated protein haploinsufficiency is linked to glomerular disease susceptibility. Science 300: 1298-1300, 2003 (Pubitemid 36618242)
36. Lowik MM, Groenen PJ, Pronk I, Lilien MR, Goldschmeding R, Dijkman HB, Levtchenko EN, Monnens LA, van den Heuvel LP: Focal segmental glomerulosclerosis in a patient homozygous for a CD2AP mutation. Kidney Int 72: 1198-1203, 2007 (Pubitemid 350059656)
37. Yang X, Letterio JJ, Lechleider RJ, Chen L, Hayman R, Gu H, Roberts AB, Deng C: Targeted disruption of SMAD3 results in impaired mucosal immunity and diminished T cell responsiveness to TGF-beta. EMBO J 18: 1280-1291, 1999 (Pubitemid 29110312)
38. Shih NY, Li J, Cotran R, Mundel P, Miner JH, Shaw AS: CD2AP localizes to the slit diaphragm and binds to nephrin via a novel C-terminal domain. Am J Pathol 159: 2303-2308, 2001 (Pubitemid 33104283)
39. Wieser R, Wrana JL, Massague J: GS domain mutations that constitutively activate T beta R-I, the downstream signaling component in the TGF-beta receptor complex. EMBO J 14: 2199-2208, 1995
40. Nishimura S, Yoshida T, Sugiura H, Shirota S, Tsuchiya K, Nihei H: CD2AP expression in a renal ischemia/reperfusion injury model and analysis of its related genes using overexpression and RNA interference technique. Am J Nephrol 25: 373-381, 2005 (Pubitemid 41160996)
41. Saeed AI, Sharov V, White J, Li J, Liang W, Bhagabati N, Braisted J, Klapa M, Currier T, Thiagarajan M, Sturn A, Snuffin M, Rezantsev A, Popov D, Ryltsov A, Kostukovich E, Borisovsky I, Liu Z, Vinsavich A, Trush V, Quackenbush J: TM4: A free, open-source system for microarray data management and analysis. Biotechniques 34: 374-378, 2003 (Pubitemid 36184095)